Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06916936 · ClinicalTrials.gov registry record · NA
Effect of Peanut Butter on Gut and Metabolic Health
A NA study of Dysbiosis, sponsored by Florida State University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06916936: Recruiting NA study of Dysbiosis, sponsored by Florida State University.
NCT06916936 is a NA study of Dysbiosis that is actively recruiting participants, run by Florida State University. The registered enrollment target is 60 participants, below the 110-participant average among 13 other Dysbiosis trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06916936, a NA study of Dysbiosis, is actively recruiting participants, sponsored by Florida State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this is parallel arm, randomized clinical trial is to learn and understand the effect of daily smooth peanut butter consumption on gut and metabolic health of children age 6-13. The main objectives are: Primary Objective: To determine the prebiotic effect of daily smooth peanut butter consumption for eight weeks on gut health, including microbiome-metabolome arrays, gut epithelial/barrier function, and gut transit time, in school-aged children. Secondary Objective(s) 1. To determine the effect of daily smooth peanut butter consumption for eight weeks on metabolic and inflammatory health markers, and measures of sleep quality in school-aged children. 2. To determine the potential mechanisms and feasibility of incorporating peanut butter into the diets of school-aged children as part of healthy, personalized nutrition. Research Intervention(s): Researchers compare two groups to see if there really is an effect of daily smooth peanut butter intake on gut and metabolic health. The two groups are: 1. The 1st condition (PB) includes a normal diet supplemented daily with personalized portion of smooth PB, sandwiched between two plain unsalted saltine crackers. 2. The 2nd condition (CTL) includes a normal diet supplemented daily with an isocaloric amount of a nut-free, vegetable oil-based chocolate spread, sandwiched between two plain unsalted saltine crackers.
Primary Outcome
Collected fecal samples will be used to determine microbiome profiles, including diversity and composition of bacteria.
Conditions Studied
Interventions
- OTHER Creamy Richards 100% Peanuts! Creamy Natural Peanut Butter
- OTHER Cadbury Milk Chocolate Spread
Study Locations (1)
Florida
- Florida State Univresity - The Gut Biome Lab - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-02-09 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06916936 shows while recruiting
NCT06916936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 110-participant average among 13 other Dysbiosis trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Dysbiosis appearing as the primary indexed condition, and to 2 interventions - of which Creamy Richards 100% Peanuts! Creamy Natural Peanut Butter is the first listed.
NCT06916936 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06916936 about?
NCT06916936 is a clinical study titled "Effect of Peanut Butter on Gut and Metabolic Health". The goal of this is parallel arm, randomized clinical trial is to learn and understand the effect of daily smooth peanut butter consumption on gut and metabolic health of children age 6-13. The main objectives are: Primary Objective: To determine the prebiotic effect of daily smooth peanut butter c...
What is the current status of trial NCT06916936?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-02-09. Estimated completion is 2026-08.
What conditions does trial NCT06916936 study?
This clinical trial studies the following conditions: Dysbiosis.
What interventions are being tested in trial NCT06916936?
The interventions under investigation include: Creamy Richards 100% Peanuts! Creamy Natural Peanut Butter (OTHER), Cadbury Milk Chocolate Spread (OTHER).
Who is sponsoring clinical trial NCT06916936?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06916936 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysbiosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06916936's enrollment target sits among peer trials
60 7th of 13 higher than 6 of 13 other Dysbiosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dysbiosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized GI Motility Responses to Diet
RECRUITING · NA
-
Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health
RECRUITING · NA
-
A Study of Healthy Microbiome, Healthy Mind
RECRUITING · NA
-
Effect of Watermelon on Gut and Cardiometabolic Health
RECRUITING · NA
-
Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention
RECRUITING · NA
-
Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI